About Formel Labs
Formel Labs is a Healthcare company based in Hyderabad (India). Pharmaceutical manufacturing of APIs and intermediates with a focus on GMP standards in India. It operates in the Healthcare and Chemicals & Materials sectors. The company has 24 employees. Its Indian entity Formel Labs Private Limited reported revenue of ₹1.60 Cr. Formel Labs offers products and services including KSMs and Intermediates and R&D Services. Its focus areas include Pharmaceuticals, Drug Manufacturing, API Production and Chemicals.
Company details
Formel Labs is viewed as a pharmaceutical entity that was established in 2020 to fill gaps in the Indian bulk drug sector. It is intended to emerge as a global leader by delivering innovative, high-quality, and cost-effective products for patients worldwide. A strong emphasis is placed on adhering to international GMP standards, fostering innovation, and maintaining customer partnerships, while improvements to life value are pursued through consistent efforts in employee and shareholder success. Ethical business practices and advanced manufacturing capabilities are highlighted in its operations.
- Headquarters Hyderabad, India
- Employees 24
- SectorsHealthcareChemicals & Materials
- Phone•••• ••••
- Social LinkedIn
- Legal Name Formel Labs Pvt Ltd
- Date of Incorporation 30 Jun, 2020
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1.60 Cr
FY 2025
- Net Loss-₹6.87 Cr
FY 2025 · -430% margin
- EBITDA-₹4.82 Cr
FY 2025 · -301% margin
- Employee Count24
Associated legal entities of Formel Labs
Formel Labs operates through Formel Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Formel Labs Private Limited CIN U24290TG2020PTC141247 | Active | 30 Jun 2020 | Hyderabad, Telangana | ₹1.6 Cr | 24 | 5 | View details |
Products & Services of Formel Labs
Formel Labs offers a comprehensive portfolio of products and services, including KSMs and Intermediates and R&D Services.
KSMs and intermediates are manufactured for drug production, serving both domestic and international markets with a focus on quality and efficiency
R&D services are provided in areas like chemistry capabilities and therapeutic categories to support pharmaceutical development
Board of directors of Formel Labs Private Limited (Formel Labs)
Formel Labs Private Limited is the primary company behind Formel Labs. The board of Formel Labs Private Limited currently have 5 directors; the longest-serving is Dandamudi Anitha, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dandamudi Anitha DIN 00025480 | Director | 30 Jun 2020 | 6 yrs 3 mo | Formel Labs Private Limited |
| Srikrishna Vardhan Vankayalapati DIN 08753755 | Director | 30 Jun 2020 | 6 yrs 3 mo | Formel Labs Private Limited |
| Raviprasad Talluru DIN 01563092 | Director | 30 Jun 2020 | 6 yrs 3 mo | Formel Labs Private Limited |
| Venkat Akshay Dandamudi DIN 08368251 | Director | 30 Jun 2020 | 6 yrs 3 mo | Formel Labs Private Limited |
| Sricharan Damavarapu DIN 08776428 | Director | 30 Jun 2020 | 6 yrs 3 mo | Formel Labs Private Limited |
Financials of Formel Labs
Figures of Formel Labs Private Limited, the primary company behind Formel Labs, for FY 2025. Revenue was ₹1.60 Cr. Net loss was -₹6.87 Cr (-430% margin). EBITDA was -₹4.82 Cr (-301% margin).
- ₹1.60 CrRevenue · FY 2025
- -₹6.87 CrNet loss · -430% margin
- -₹4.82 CrEBITDA · -301% margin
- ₹47.92 CrPaid-up capital
- 24Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Formel Labs Private Limited are on its company page.
Detailed financial statements for Formel Labs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Formel Labs
Formel Labs is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Formel Labs has 24 employees.
The primary company behind Formel Labs, Formel Labs Private Limited, reported revenue of ₹1.60 Cr for FY 2025.
Formel Labs is viewed as a pharmaceutical entity that was established in 2020 to fill gaps in the Indian bulk drug sector. It is intended to emerge as a global leader by delivering innovative, high-quality, and cost-effective products for patients worldwide. A strong emphasis is placed on adhering to international GMP standards, fostering innovation, and maintaining customer partnerships, while improvements to life value are pursued through consistent efforts in employee and shareholder success. Ethical business practices and advanced manufacturing capabilities are highlighted in its operations.
Formel Labs offers KSMs and Intermediates and R&D Services.
Formel Labs operates through Formel Labs Private Limited.
The legal entities of Formel Labs currently have 5 directors, including Dandamudi Anitha, Srikrishna Vardhan Vankayalapati, Raviprasad Talluru and others.